Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.40 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1607
    -0.0076 (-0.65%)
     
  • GBP/USD

    1.2373
    -0.0065 (-0.52%)
     
  • Bitcoin GBP

    52,256.04
    -201.88 (-0.38%)
     
  • CMC Crypto 200

    1,340.52
    +27.90 (+2.13%)
     
  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     
  • DOW

    37,986.40
    +211.00 (+0.56%)
     
  • CRUDE OIL

    83.24
    +0.10 (+0.12%)
     
  • GOLD FUTURES

    2,406.70
    -7.10 (-0.29%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.76 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

Global Neurostimulation Devices Market to Reach $13.2 Billion by 2030

ReportLinker
ReportLinker

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

New York, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Neurostimulation Devices Industry" - https://www.reportlinker.com/p05956896/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Neurostimulation Devices Market to Reach $13.2 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Neurostimulation Devices estimated at US$17.3 Billion in the year 2022, is projected to reach a revised size of US$13.2 Billion by 2030, growing at a CAGR of -3.3% over the analysis period 2022-2030. Spinal Cord Stimulation Devices, one of the segments analyzed in the report, is projected to record a -2.6% CAGR and reach US$4.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Deep Brain Stimulation Devices segment is readjusted to a revised -3.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $4.6 Billion, While China is Forecast to Grow at -0.1% CAGR

The Neurostimulation Devices market in the U.S. is estimated at US$4.6 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.1 Billion by the year 2030 trailing a CAGR of -0.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at -6.7% and -2.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately -5.6% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.8 Billion by the year 2030.

Select Competitors (Total 32 Featured)
- Boston Scientific Corporation
- LivaNova PLC
- Medtronic, Inc.
- NeuroPace, Inc.
- NeuroSigma, Inc.


Read the full report: https://www.reportlinker.com/p05956896/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Neurostimulation Devices - Global Key Competitors Percentage
Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Neurostimulation Devices by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR

Table 2: World Historic Review for Neurostimulation Devices by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR

Table 3: World 18-Year Perspective for Neurostimulation Devices
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for Deep
Brain Stimulation Devices by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR

Table 5: World Historic Review for Deep Brain Stimulation
Devices by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2021 and % CAGR

Table 6: World 18-Year Perspective for Deep Brain Stimulation
Devices by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2023 &
2030

Table 7: World Recent Past, Current & Future Analysis for
Spinal Cord Stimulation Devices by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2022 through 2030 and % CAGR

Table 8: World Historic Review for Spinal Cord Stimulation
Devices by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2021 and % CAGR

Table 9: World 18-Year Perspective for Spinal Cord Stimulation
Devices by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2023 &
2030

Table 10: World Recent Past, Current & Future Analysis for
Gastric Electric Stimulation Devices by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2022 through 2030 and % CAGR

Table 11: World Historic Review for Gastric Electric
Stimulation Devices by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2021 and % CAGR

Table 12: World 18-Year Perspective for Gastric Electric
Stimulation Devices by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Vagus Nerve Stimulation Devices by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2022 through 2030 and % CAGR

Table 14: World Historic Review for Vagus Nerve Stimulation
Devices by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2021 and % CAGR

Table 15: World 18-Year Perspective for Vagus Nerve Stimulation
Devices by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2023 &
2030

Table 16: World Recent Past, Current & Future Analysis for
Sacral Nerve Stimulation Devices by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2022 through 2030 and % CAGR

Table 17: World Historic Review for Sacral Nerve Stimulation
Devices by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2021 and % CAGR

Table 18: World 18-Year Perspective for Sacral Nerve
Stimulation Devices by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for
Other Products by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 20: World Historic Review for Other Products by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR

Table 21: World 18-Year Perspective for Other Products by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2023 & 2030

Table 22: World Recent Past, Current & Future Analysis for
Epilepsy by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 23: World Historic Review for Epilepsy by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2021 and
% CAGR

Table 24: World 18-Year Perspective for Epilepsy by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2023 & 2030

Table 25: World Recent Past, Current & Future Analysis for Pain
Management by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 26: World Historic Review for Pain Management by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR

Table 27: World 18-Year Perspective for Pain Management by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2023 & 2030

Table 28: World Recent Past, Current & Future Analysis for
Urinary & Fecal Incontinence by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2022 through 2030 and % CAGR

Table 29: World Historic Review for Urinary & Fecal
Incontinence by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2021 and % CAGR

Table 30: World 18-Year Perspective for Urinary & Fecal
Incontinence by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2023 & 2030

Table 31: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 32: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR

Table 33: World 18-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2023 & 2030

Table 34: World Recent Past, Current & Future Analysis for
Parkinson`s by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 35: World Historic Review for Parkinson`s by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2021 and
% CAGR

Table 36: World 18-Year Perspective for Parkinson`s by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2023 & 2030

Table 37: World Recent Past, Current & Future Analysis for
Alzheimer`s by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 38: World Historic Review for Alzheimer`s by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2021 and
% CAGR

Table 39: World 18-Year Perspective for Alzheimer`s by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2023 & 2030

Table 40: World Neurostimulation Devices Market Analysis of
Annual Sales in US$ Million for Years 2012 through 2030

III. MARKET ANALYSIS

UNITED STATES
Neurostimulation Devices Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2023 (E)
Table 41: USA Recent Past, Current & Future Analysis for
Neurostimulation Devices by Product - Spinal Cord Stimulation
Devices, Deep Brain Stimulation Devices, Sacral Nerve
Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric
Electric Stimulation Devices and Other Products - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 42: USA Historic Review for Neurostimulation Devices by
Product - Spinal Cord Stimulation Devices, Deep Brain
Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus
Nerve Stimulation Devices, Gastric Electric Stimulation Devices
and Other Products Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2021 and % CAGR

Table 43: USA 18-Year Perspective for Neurostimulation Devices
by Product - Percentage Breakdown of Value Sales for Spinal
Cord Stimulation Devices, Deep Brain Stimulation Devices,
Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation
Devices, Gastric Electric Stimulation Devices and Other
Products for the Years 2012, 2023 & 2030

Table 44: USA Recent Past, Current & Future Analysis for
Neurostimulation Devices by Application - Pain Management,
Epilepsy, Parkinson`s, Urinary & Fecal Incontinence,
Alzheimer`s and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 45: USA Historic Review for Neurostimulation Devices by
Application - Pain Management, Epilepsy, Parkinson`s, Urinary &
Fecal Incontinence, Alzheimer`s and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR

Table 46: USA 18-Year Perspective for Neurostimulation Devices
by Application - Percentage Breakdown of Value Sales for Pain
Management, Epilepsy, Parkinson`s, Urinary & Fecal
Incontinence, Alzheimer`s and Other Applications for the Years
2012, 2023 & 2030

CANADA
Table 47: Canada Recent Past, Current & Future Analysis for
Neurostimulation Devices by Product - Spinal Cord Stimulation
Devices, Deep Brain Stimulation Devices, Sacral Nerve
Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric
Electric Stimulation Devices and Other Products - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 48: Canada Historic Review for Neurostimulation Devices
by Product - Spinal Cord Stimulation Devices, Deep Brain
Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus
Nerve Stimulation Devices, Gastric Electric Stimulation Devices
and Other Products Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2021 and % CAGR

Table 49: Canada 18-Year Perspective for Neurostimulation
Devices by Product - Percentage Breakdown of Value Sales for
Spinal Cord Stimulation Devices, Deep Brain Stimulation
Devices, Sacral Nerve Stimulation Devices, Vagus Nerve
Stimulation Devices, Gastric Electric Stimulation Devices and
Other Products for the Years 2012, 2023 & 2030

Table 50: Canada Recent Past, Current & Future Analysis for
Neurostimulation Devices by Application - Pain Management,
Epilepsy, Parkinson`s, Urinary & Fecal Incontinence,
Alzheimer`s and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 51: Canada Historic Review for Neurostimulation Devices
by Application - Pain Management, Epilepsy, Parkinson`s,
Urinary & Fecal Incontinence, Alzheimer`s and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2021 and % CAGR

Table 52: Canada 18-Year Perspective for Neurostimulation
Devices by Application - Percentage Breakdown of Value Sales
for Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal
Incontinence, Alzheimer`s and Other Applications for the Years
2012, 2023 & 2030

JAPAN
Neurostimulation Devices Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2023 (E)
Table 53: Japan Recent Past, Current & Future Analysis for
Neurostimulation Devices by Product - Spinal Cord Stimulation
Devices, Deep Brain Stimulation Devices, Sacral Nerve
Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric
Electric Stimulation Devices and Other Products - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 54: Japan Historic Review for Neurostimulation Devices by
Product - Spinal Cord Stimulation Devices, Deep Brain
Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus
Nerve Stimulation Devices, Gastric Electric Stimulation Devices
and Other Products Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2021 and % CAGR

Table 55: Japan 18-Year Perspective for Neurostimulation
Devices by Product - Percentage Breakdown of Value Sales for
Spinal Cord Stimulation Devices, Deep Brain Stimulation
Devices, Sacral Nerve Stimulation Devices, Vagus Nerve
Stimulation Devices, Gastric Electric Stimulation Devices and
Other Products for the Years 2012, 2023 & 2030

Table 56: Japan Recent Past, Current & Future Analysis for
Neurostimulation Devices by Application - Pain Management,
Epilepsy, Parkinson`s, Urinary & Fecal Incontinence,
Alzheimer`s and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 57: Japan Historic Review for Neurostimulation Devices by
Application - Pain Management, Epilepsy, Parkinson`s, Urinary &
Fecal Incontinence, Alzheimer`s and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR

Table 58: Japan 18-Year Perspective for Neurostimulation
Devices by Application - Percentage Breakdown of Value Sales
for Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal
Incontinence, Alzheimer`s and Other Applications for the Years
2012, 2023 & 2030

CHINA
Neurostimulation Devices Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2023 (E)
Table 59: China Recent Past, Current & Future Analysis for
Neurostimulation Devices by Product - Spinal Cord Stimulation
Devices, Deep Brain Stimulation Devices, Sacral Nerve
Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric
Electric Stimulation Devices and Other Products - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 60: China Historic Review for Neurostimulation Devices by
Product - Spinal Cord Stimulation Devices, Deep Brain
Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus
Nerve Stimulation Devices, Gastric Electric Stimulation Devices
and Other Products Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2021 and % CAGR

Table 61: China 18-Year Perspective for Neurostimulation
Devices by Product - Percentage Breakdown of Value Sales for
Spinal Cord Stimulation Devices, Deep Brain Stimulation
Devices, Sacral Nerve Stimulation Devices, Vagus Nerve
Stimulation Devices, Gastric Electric Stimulation Devices and
Other Products for the Years 2012, 2023 & 2030

Table 62: China Recent Past, Current & Future Analysis for
Neurostimulation Devices by Application - Pain Management,
Epilepsy, Parkinson`s, Urinary & Fecal Incontinence,
Alzheimer`s and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 63: China Historic Review for Neurostimulation Devices by
Application - Pain Management, Epilepsy, Parkinson`s, Urinary &
Fecal Incontinence, Alzheimer`s and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR

Table 64: China 18-Year Perspective for Neurostimulation
Devices by Application - Percentage Breakdown of Value Sales
for Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal
Incontinence, Alzheimer`s and Other Applications for the Years
2012, 2023 & 2030

EUROPE
Neurostimulation Devices Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2023 (E)
Table 65: Europe Recent Past, Current & Future Analysis for
Neurostimulation Devices by Geographic Region - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 66: Europe Historic Review for Neurostimulation Devices
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2021 and %
CAGR

Table 67: Europe 18-Year Perspective for Neurostimulation
Devices by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2012, 2023 & 2030

Table 68: Europe Recent Past, Current & Future Analysis for
Neurostimulation Devices by Product - Spinal Cord Stimulation
Devices, Deep Brain Stimulation Devices, Sacral Nerve
Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric
Electric Stimulation Devices and Other Products - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 69: Europe Historic Review for Neurostimulation Devices
by Product - Spinal Cord Stimulation Devices, Deep Brain
Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus
Nerve Stimulation Devices, Gastric Electric Stimulation Devices
and Other Products Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2021 and % CAGR

Table 70: Europe 18-Year Perspective for Neurostimulation
Devices by Product - Percentage Breakdown of Value Sales for
Spinal Cord Stimulation Devices, Deep Brain Stimulation
Devices, Sacral Nerve Stimulation Devices, Vagus Nerve
Stimulation Devices, Gastric Electric Stimulation Devices and
Other Products for the Years 2012, 2023 & 2030

Table 71: Europe Recent Past, Current & Future Analysis for
Neurostimulation Devices by Application - Pain Management,
Epilepsy, Parkinson`s, Urinary & Fecal Incontinence,
Alzheimer`s and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 72: Europe Historic Review for Neurostimulation Devices
by Application - Pain Management, Epilepsy, Parkinson`s,
Urinary & Fecal Incontinence, Alzheimer`s and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2021 and % CAGR

Table 73: Europe 18-Year Perspective for Neurostimulation
Devices by Application - Percentage Breakdown of Value Sales
for Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal
Incontinence, Alzheimer`s and Other Applications for the Years
2012, 2023 & 2030

FRANCE
Neurostimulation Devices Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2023 (E)
Table 74: France Recent Past, Current & Future Analysis for
Neurostimulation Devices by Product - Spinal Cord Stimulation
Devices, Deep Brain Stimulation Devices, Sacral Nerve
Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric
Electric Stimulation Devices and Other Products - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 75: France Historic Review for Neurostimulation Devices
by Product - Spinal Cord Stimulation Devices, Deep Brain
Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus
Nerve Stimulation Devices, Gastric Electric Stimulation Devices
and Other Products Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2021 and % CAGR

Table 76: France 18-Year Perspective for Neurostimulation
Devices by Product - Percentage Breakdown of Value Sales for
Spinal Cord Stimulation Devices, Deep Brain Stimulation
Devices, Sacral Nerve Stimulation Devices, Vagus Nerve
Stimulation Devices, Gastric Electric Stimulation Devices and
Other Products for the Years 2012, 2023 & 2030

Table 77: France Recent Past, Current & Future Analysis for
Neurostimulation Devices by Application - Pain Management,
Epilepsy, Parkinson`s, Urinary & Fecal Incontinence,
Alzheimer`s and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 78: France Historic Review for Neurostimulation Devices
by Application - Pain Management, Epilepsy, Parkinson`s,
Urinary & Fecal Incontinence, Alzheimer`s and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2021 and % CAGR

Table 79: France 18-Year Perspective for Neurostimulation
Devices by Application - Percentage Breakdown of Value Sales
for Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal
Incontinence, Alzheimer`s and Other Applications for the Years
2012, 2023 & 2030

GERMANY
Neurostimulation Devices Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2023 (E)
Table 80: Germany Recent Past, Current & Future Analysis for
Neurostimulation Devices by Product - Spinal Cord Stimulation
Devices, Deep Brain Stimulation Devices, Sacral Nerve
Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric
Electric Stimulation Devices and Other Products - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 81: Germany Historic Review for Neurostimulation Devices
by Product - Spinal Cord Stimulation Devices, Deep Brain
Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus
Nerve Stimulation Devices, Gastric Electric Stimulation Devices
and Other Products Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2021 and % CAGR

Table 82: Germany 18-Year Perspective for Neurostimulation
Devices by Product - Percentage Breakdown of Value Sales for
Spinal Cord Stimulation Devices, Deep Brain Stimulation
Devices, Sacral Nerve Stimulation Devices, Vagus Nerve
Stimulation Devices, Gastric Electric Stimulation Devices and
Other Products for the Years 2012, 2023 & 2030

Table 83: Germany Recent Past, Current & Future Analysis for
Neurostimulation Devices by Application - Pain Management,
Epilepsy, Parkinson`s, Urinary & Fecal Incontinence,
Alzheimer`s and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 84: Germany Historic Review for Neurostimulation Devices
by Application - Pain Management, Epilepsy, Parkinson`s,
Urinary & Fecal Incontinence, Alzheimer`s and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2021 and % CAGR

Table 85: Germany 18-Year Perspective for Neurostimulation
Devices by Application - Percentage Breakdown of Value Sales
for Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal
Incontinence, Alzheimer`s and Other Applications for the Years
2012, 2023 & 2030

ITALY
Table 86: Italy Recent Past, Current & Future Analysis for
Neurostimulation Devices by Product - Spinal Cord Stimulation
Devices, Deep Brain Stimulation Devices, Sacral Nerve
Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric
Electric Stimulation Devices and Other Products - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 87: Italy Historic Review for Neurostimulation Devices by
Product - Spinal Cord Stimulation Devices, Deep Brain
Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus
Nerve Stimulation Devices, Gastric Electric Stimulation Devices
and Other Products Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2021 and % CAGR

Table 88: Italy 18-Year Perspective for Neurostimulation
Devices by Product - Percentage Breakdown of Value Sales for
Spinal Cord Stimulation Devices, Deep Brain Stimulation
Devices, Sacral Nerve Stimulation Devices, Vagus Nerve
Stimulation Devices, Gastric Electric Stimulation Devices and
Other Products for the Years 2012, 2023 & 2030

Table 89: Italy Recent Past, Current & Future Analysis for
Neurostimulation Devices by Application - Pain Management,
Epilepsy, Parkinson`s, Urinary & Fecal Incontinence,
Alzheimer`s and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 90: Italy Historic Review for Neurostimulation Devices by
Application - Pain Management, Epilepsy, Parkinson`s, Urinary &
Fecal Incontinence, Alzheimer`s and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR

Table 91: Italy 18-Year Perspective for Neurostimulation
Devices by Application - Percentage Breakdown of Value Sales
for Pain Management, Epilepsy, Parkinson`s, Urinary & Fecal
Incontinence, Alzheimer`s and Other Applications for the Years
2012, 2023 & 2030

UNITED KINGDOM
Neurostimulation Devices Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United Kingdom for 2023 (E)
Table 92: UK Recent Past, Current & Future Analysis for
Neurostimulation Devices by Product - Spinal Cord Stimulation
Devices, Deep Brain Stimulation Devices, Sacral Nerve
Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric
Electric Stimulation Devices and Other Products - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 93: UK Historic Review for Neurostimulation Devices by
Product - Spinal Cord Stimulation Devices, Deep Brain
Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus
Nerve Stimulation Devices, Gastric Electric Stimulation Devices
and Other Products Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2021 and % CAGR

Table 94: UK 18-Year Perspective for Neurostimulation Devices
by Product - Percentage Breakdown of Value Sales for Spinal
Cord Stimulation Devices, Deep Brain Stimulation Devices,
Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation
Devices, Gastric Electric Stimulation Devices and Other
Products for the Years 2012, 2023 & 2030

Table 95: UK Recent Past, Current & Future Analysis for
Neurostimulation Devices by Application - Pain Management,
Epilepsy, Parkinson`s, Urinary & Fecal Incontinence,
Alzheimer`s and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 96: UK Historic Review for Neurostimulation Devices by
Application - Pain Management, Epilepsy, Parkinson`s, Urinary &
Fecal Incontinence, Alzheimer`s and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2021 and % CAGR

Table 97: UK 18-Year Perspective for Neurostimulation Devices
by Application - Percentage Breakdown of Value Sales for Pain
Management, Epilepsy, Parkinson`s, Urinary & Fecal
Incontinence, Alzheimer`s and Other Applications for the Years
2012, 2023 & 2030

SPAIN
Table 98: Spain Recent Past, Current & Future Analysis for
Neurostimulation Devices by Product - Spinal Cord Stimulation
Devices, Deep Brain Stimulation Devices, Sacral Nerve
Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric
Electric Stimulation Devices and Other Products - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 99: Spain Historic Review for Neurostimulation Devices by
Product - Spinal Cord Stimulation Devices, Deep Brain
Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus
Nerve Stimulation Devices, Gastric Electric Stimulation Devices
and Other Products Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2021 and % CAGR

Table 100: Spain 18-Year Perspective for Neurostimulation
Devices by Product - Percentage Breakdown of Value Sales for
Spinal Cord Stimulation Devices, Deep Brain Stimulation
Devices, Sacral Nerve Stimulation Devices, Vagus Nerve
Stimulation Devices, Gastric Electric Stimulation Devices and
Other Products for the Years 2012, 2023 & 2030

Table 101: Spain Recent Past, Current & Future Analysis for
Neurostimulation Devices by Application - Pain Management,
Epilepsy, Parkinson`s, Urinary & Fecal Incontinence,
Alzheimer`s and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 102: Spain Historic Review for Neurostimulation Devices
by Application - Pain Management, Epilepsy, Parkinson`s,

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05956896/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001